Nucleophosmin/B23 is a negative regulator of estrogen receptor α expression via AP2γ in endometrial cancer cells

Endometrial cancers expressing estrogen and progesterone receptors respond to hormonal therapy. The disappearance of steroid hormone receptor expression is common in patients with recurrent disease, ultimately hampering the clinical utility of hormonal therapy. Here, we demonstrate for the first tim...

ver descrição completa

Na minha lista:
Detalhes bibliográficos
Publicado no:Oncotarget
Main Authors: Lin, Chiao-Yun, Chao, Angel, Wang, Tzu-Hao, Lee, Li-Yu, Yang, Lan-Yan, Tsai, Chia-Lung, Wang, Hsin-Shih, Lai, Chyong-Huey
Formato: Artigo
Idioma:Inglês
Publicado em: Impact Journals LLC 2016
Assuntos:
Research Paper
Acesso em linha:https://ncbi.nlm.nih.gov/pmc/articles/PMC5312367/
https://ncbi.nlm.nih.gov/pubmed/27527851
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.18632/oncotarget.11048
Tags: Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!

Registos relacionados